A5016085159- Childhood Cancer Survivors' Quality of Life
- Family Support in Illness
- Palliative Care and End-of-Life Issues
- Adolescent and Pediatric Healthcare
- Family and Patient Care in Intensive Care Units
- Ethics in Clinical Research
- Advanced Breast Cancer Therapies
- Neuroblastoma Research and Treatments
- Family and Disability Support Research
- Colorectal and Anal Carcinomas
- Ethics and Legal Issues in Pediatric Healthcare
- Bacterial Identification and Susceptibility Testing
- Breast Cancer Treatment Studies
- Neutropenia and Cancer Infections
- Central Venous Catheters and Hemodialysis
- Lung Cancer Treatments and Mutations
Hartford Financial Services (United States)
2023-2024
Center for Cancer and Blood Disorders
2024
Connecticut Children's Medical Center
2019-2024
Charité - Universitätsmedizin Berlin
2019
Philipps University of Marburg
2019
Klinikum rechts der Isar
2019
Myriad (Germany)
2019
Helios Hospital Berlin-Buch
2019
Technical University of Munich
2019
Background: Increased childhood cancer survival rates have spurred a new body of research pertaining to the cancer-survivorship continuum. Literature suggests lack and guidelines for care at end treatment (EOT). To improve transition survivorship determine any posttreatment challenges, this study explored experiences survivors (CCSs), parents/caregivers, pediatric oncology health professionals (HCPs) EOT. Method: This employed mixed methods design. EOT Questionnaires were completed by CCSs...
Background To the authors' knowledge, information regarding whether daily bathing with chlorhexidine gluconate (CHG) reduces central line–associated bloodstream infection (CLABSI) in pediatric oncology patients and those undergoing hematopoietic stem cell transplantation (HCT) is limited. Methods In current multicenter, randomized, double‐blind, placebo‐controlled trial, aged ≥2 months <22 years cancer or allogeneic HCT were randomized 1:1 to once‐daily 2% CHG‐impregnated cloths control...
The end of treatment (EOT) is a significant time point along the childhood cancer treatment-survivorship continuum, and recognized as when survivors (CCS) their families experience vulnerability stress. There call by healthcare professionals alike for standardized, comprehensive EOT services to successfully navigate through this transition period better cope with posttreatment medical, physical, social-emotional issues.
When individuals participate in health care research, the choice often affects entire family. Researchers are responsible for protecting participants and minimizing any burdens research may place on them. Resources to educate potential study about these issues from a family perspective lacking. A family-focused, evidence-based resource was created families prompt discussion prior their consenting enrollment research. The includes key relevant questions consider related participation revised...
Abstract Background: In node negative and 1-3 positive nodes breast cancer patients with hormone receptor (HR+), HER2-negative (HER2-) early-stage the indication for chemotherapy is based on clinical pathologic risk stratification (tumor size, nodal status, grading, quantitative ER, progesterone Ki67). For further decision-making, EndoPredict test, which combines a molecular signature factors tumor size stratifies into “low risk" or “high risk” groups. Level I-B- evidence demonstrates, that...